These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 8184243)
1. [Current trends in the treatment of deep venous thrombosis]. Eichlisberger R; Frauchiger B; Jäger K Schweiz Rundsch Med Prax; 1994 Feb; 83(7):183-8. PubMed ID: 8184243 [TBL] [Abstract][Full Text] [Related]
2. The home treatment of deep vein thrombosis with low molecular weight heparin, forced mobilisation and compression. Labas P; Ohrádka B; Vladimír J; Cambal M Int Angiol; 2000 Dec; 19(4):303-7. PubMed ID: 11305727 [TBL] [Abstract][Full Text] [Related]
3. Comparison of six-month outcome of patients initially treated for acute deep vein thrombosis with a low molecular weight heparin Certoparin at a fixed, body-weight-independent dosage or unfractionated heparin. Harenberg J; Riess H; Büller HR; Brom J; Weidinger G; Huisman MV Haematologica; 2003 Oct; 88(10):1157-62. PubMed ID: 14555312 [TBL] [Abstract][Full Text] [Related]
4. [Deep venous thrombosis of the leg. Will it be acute ambulatory therapy in the future?]. Diehm C; Stammler F; Lawall H MMW Fortschr Med; 2002 Sep; 144(35-36):32-4, 36-8. PubMed ID: 12380353 [TBL] [Abstract][Full Text] [Related]
5. [Drug therapy of deep venous thrombosis]. Bounameaux H Ther Umsch; 1996 Apr; 53(4):272-6. PubMed ID: 8658349 [TBL] [Abstract][Full Text] [Related]
6. Treatment of proximal deep-vein thrombosis with the oral direct factor Xa inhibitor rivaroxaban (BAY 59-7939): the ODIXa-DVT (Oral Direct Factor Xa Inhibitor BAY 59-7939 in Patients With Acute Symptomatic Deep-Vein Thrombosis) study. Agnelli G; Gallus A; Goldhaber SZ; Haas S; Huisman MV; Hull RD; Kakkar AK; Misselwitz F; Schellong S; Circulation; 2007 Jul; 116(2):180-7. PubMed ID: 17576867 [TBL] [Abstract][Full Text] [Related]
7. Treatment of deep vein thrombosis with continuous intravenous infusion of LMWH in children--an alternative to subcutaneous application when needed. Blatný J; Fiamoli V Vnitr Lek; 2009 Mar; 55(3):227-32. PubMed ID: 19378852 [TBL] [Abstract][Full Text] [Related]
8. Low-molecular-weight heparin (LMWH) in the treatment of thrombosis. Holzheimer RG Eur J Med Res; 2004 Apr; 9(4):225-39. PubMed ID: 15210403 [TBL] [Abstract][Full Text] [Related]
9. Home treatment of deep vein thrombosis: a two-years experience of a single institution. Grau E; Real E; Pastor E; Viciano V; Aguiló J Haematologica; 1998 May; 83(5):438-41. PubMed ID: 9658729 [TBL] [Abstract][Full Text] [Related]
10. Hemostatic activation under anticoagulant treatment: a comparison of unfractionated heparin vs. nadroparin in the treatment of proximal deep vein thrombosis. Stricker H; Marchetti O; Haeberli A; Mombelli G Thromb Haemost; 1999 Oct; 82(4):1227-31. PubMed ID: 10544903 [TBL] [Abstract][Full Text] [Related]
11. DVT and pulmonary embolism: Part II. Treatment and prevention. Ramzi DW; Leeper KV Am Fam Physician; 2004 Jun; 69(12):2841-8. PubMed ID: 15222649 [TBL] [Abstract][Full Text] [Related]
13. Prophylaxis of thromboembolic disease with RO-11 (ROVI), during abdominal surgery. EMRO1 (Grupo Fstudio Multicintrico RO-11). Moreno Gonzalez E; Fontcuberta J; de la Llama F Hepatogastroenterology; 1996; 43(9):744-7. PubMed ID: 8799424 [TBL] [Abstract][Full Text] [Related]
14. An open-label, comparative study of the efficacy and safety of once-daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep-vein thrombosis. Ramacciotti E; Araújo GR; Lastoria S; Maffei FH; Karaoglan de Moura L; Michaelis W; Sandri JL; Dietrich-Neto F; Thromb Res; 2004; 114(3):149-53. PubMed ID: 15342210 [TBL] [Abstract][Full Text] [Related]
15. Deferment of objective assessment of deep vein thrombosis and pulmonary embolism without increased risk of thrombosis: a practical approach based on the pretest clinical model, D-dimer testing, and the use of low-molecular-weight heparins. Siragusa S; Anastasio R; Porta C; Falaschi F; Pirrelli S; Palmieri P; Gamba G; Granzow K; Malato A; Minardi V; Tatoni P; Bressan MA; Mariani G Arch Intern Med; 2004 Dec 13-27; 164(22):2477-82. PubMed ID: 15596639 [TBL] [Abstract][Full Text] [Related]
16. Prophylaxis and treatment of deep vein thrombosis in general surgery. Gutt CN; Oniu T; Wolkener F; Mehrabi A; Mistry S; Büchler MW Am J Surg; 2005 Jan; 189(1):14-22. PubMed ID: 15701484 [TBL] [Abstract][Full Text] [Related]
17. [How to provide practical treatment for ambulatory patients with deep venous thrombosis]. Achkar A; Samama MM J Mal Vasc; 1999 Feb; 24(1):58-65. PubMed ID: 10192039 [TBL] [Abstract][Full Text] [Related]
18. Low molecular weight heparin for deep vein thrombosis in glioma patients. Schmidt F; Faul C; Dichgans J; Weller M J Neurol; 2002 Oct; 249(10):1409-12. PubMed ID: 12382158 [TBL] [Abstract][Full Text] [Related]
19. Mobilization versus immobilization in the treatment of acute proximal deep venous thrombosis: a prospective, randomized, open, multicentre trial. Jünger M; Diehm C; Störiko H; Hach-Wunderle V; Heidrich H; Karasch T; Ochs HR; Ranft J; Sannwald GA; Strölin A; Janssen D Curr Med Res Opin; 2006 Mar; 22(3):593-602. PubMed ID: 16574042 [TBL] [Abstract][Full Text] [Related]
20. Subcutaneous low-molecular-weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis. Simonneau G; Charbonnier B; Decousus H; Planchon B; Ninet J; Sie P; Silsiguen M; Combe S Arch Intern Med; 1993 Jul; 153(13):1541-6. PubMed ID: 8391792 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]